SEATTLE — Bartell Drugs has announced three the addition of three new members to its board of directors. The new additions — Kathy Gersch, Marck Schwartz and Kristi Marchbanks — have experience with online and brick-and-mortar retail, as well as work on other companies’ boards.
Gersch, former VP, chief marketing officer and GM of drugstore.com, has experience in leading the transformation of companies around the world in such sectors as healthcare, CPG, retail, energy and aerospace through her company Kotter International. She also has experience as an independent consultant and has previously served as VP finance, strategic planning and administration for Nordstrom Product Group and VP at Façconable International.
Schwartz possesses more than 20 years of c-suite experience and has been a board member of such companies as Starbucks. He advises the CEOs of 18 portfolio companies in the food, technology, healthcare and manufacturing spaces as an investor. He is the co-founder of grocery retailer Bodega Latina (El Super).
Marchbanks has worked in both the start-up and Fortune 500 business spaces, and has experience as a board member and corporate strategy executive. In her career, she has started new companies, launched products and scaled businesses by accelerating revenue growth, and was among the first to commercialize big data, cloud computing and software-as-a-service.
“We are delighted to add these three very talented outside directors to our Board,” vice chairman and treasurer Jean Bartell Barber said. “I anticipate that they will provide significant strategic guidance to our company.”
Alongside Bartell Barber, George Bartell, who is continuing in his role as chairman, is representing the Bartell family. Non-family board members are Shelley Milano, currently general counsel at retailer L Brands; Bill Brakken, former CFO of Lanoga Corporation; and Frank Segrave, formerly SVP at Cardinal Health, VP Pharmacy at Walmart, and currently founder and CEO of Silvergate Pharmaceuticals.